Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (10577)	6/21/2018 5:24:40 PM
From: HardToFind	3 Recommendations Recommended By BoredMember drkaz old 'n cranky Read Replies (2) \| Respond to of 12871

You see Diwan as a real inept incompetent person only interested in himself. You're painting it too black & white. I know the man has his areas of competence, science & chemical engineering being two of them. As a president/CEO of a publicly traded company, he has not displayed competence or integrity as a steward of shareholder capital. I do believe he's interested in the shareholders and wants the company to succeed, but not as much as he wants to control and be overcompensated by NNVC. I think the corporate structure and shareholder licensing agreement make that abundantly clear. Any potential CEO would jump at the opportunity. Financiers, too. I disagree. If I had the CEO skill set and a good reputation, I would pass on such an opportunity. Many competent CEOs will look at the company and consider the corporate structure and shareholder treatment situation too ethically challenged, and consider Diwan to be too controlling of the business and willing to enrich himself. I am worried that Diwan may hire an incompetent yes-man, because that's the only kind of CEO candidates interested in the position. If I were a financier, first, I would be willing to walk from any potential deal. Second, I would wait for NNVC to go bankrupt, and then I would renegotiate the licensing terms directly with TheraCour. I would not buy into the shitty deal that the current NNVC shareholders have today. I'm also concerned that either Diwan will sign up for massive dilution of the shareholders, or the company will go bankrupt. If he goes the massive dilution route, he will find a way to issue enough Series A shares to continue to control the company. Largely the insiders will not suffer like the common shareholders will. And recapitalizing NNVC through massive dilution will allow Diwan and TheraCour to continue reaping outsized rewards whether they are able to build a business and deliver a marketable product or not. Diwan has structured the enterprise to have two boats. NNVC - the RISK boat, and TheraCour - the REWARD boat. Although Diwan has tickets on both boats, he and his business interests ride in the REWARD boat and somewhat remotely steers the RISK boat where NNVC shareholders reside. He has no interest in being in the same boat with the shareholders, but he does want to steer it for TheraCour's benefit.